Introduction {#S0001}
============

Rheumatoid arthritis (RA) is a polygenic, autoimmune, inflammatory disease that mainly affects the joints.[@CIT0001],[@CIT0002] It is prevalent in 0.5% to 1% population of the world.[@CIT0003] Characteristics of the disease include inflammation of joints, persistent synovitis and bone erosion primarily influencing peripheral joints.[@CIT0004] It usually exhibits a symmetric distribution. If not treated timely, consequences may include joint deformity, disability and even death in certain cases. The organs effected as a result of extra-articular manifestations of RA include heart, skin, lungs and eyes.[@CIT0005] Early and accurate diagnosis and timely initiation of treatment may help curb the disease to a significant extent. Current treatment options include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics and combination therapy.[@CIT0006] Methotrexate (MTX) is usually the drug of choice preferred by rheumatologists because of its potent efficacy. But, it comes with its own side effects which include gastrointestinal disorders, infections, pneumonitis, hepatic dysregulation and nephrotoxicity.[@CIT0007] Tocilizumab, leflunomide, rituximab and tofacitinib are other major highly targeted drugs that have revolutionized the management of rheumatoid arthritis. Still, a persistent concern for clinicians is the elevated risk of infections that is associated with these treatment options.[@CIT0008] In this state of events, it is essential that scientists explore an alternative therapeutic avenue for the control of this disease. One of such options is nanotherapy. Nanoparticles not only have increased bioavailability but also show less toxicity. They have the advantage of controlled release at the target site.[@CIT0009]

One other vital observation made by scientists studying rheumatoid arthritis was that selenium concentration is decreased in the synovial fluid, plasma, leukocytes and erythrocytes of patients suffering from rheumatoid arthritis.[@CIT0010]--[@CIT0012] Selenium serves as the catalytic center of enzyme glutathione peroxidase which plays a key role in body's redox regulation and consequently controls inflammatory pathways.[@CIT0013] Selenium nanoparticles (SeNP), thus, present an attractive solution to this problem as the traditional supplements usually have increased toxicity and low absorption. SeNP have also exhibited antioxidant, anti-inflammatory and immunomodulatory activities in previous studies.[@CIT0014],[@CIT0015]

When it comes to the synthesis of nanoparticles, there are multiple approaches involved which include physical, chemical and biological methods. Physical and chemical synthesis techniques have certain drawbacks which include enormous energy consumption, high costs, utilization of toxic solvents and formation of hazardous by-products. In contrast, the biggest advantage of biological synthetic method is the environment-friendly nature of the procedure.[@CIT0016] Furthermore, among the biological methods, plant-mediated synthetic approaches are cost-effective, low maintenance and nontoxic.[@CIT0017] *Foeniculum vulgare* Mill. is a medicinal plant that has been used to treat multiple ailments for decades and is reported to display anti-inflammatory, antioxidant, antimicrobial and hepatoprotective activities.[@CIT0018] It is now being used by nano-scientists in the synthesis of nanoparticles. Previously, gold and silver nanoparticles have been made using this plant.[@CIT0019],[@CIT0020]

This study, thus, aims to combine the antioxidant and anti-inflammatory therapeutic potential of *Foeniculum vulgare* Mill. plant and SeNP and utilize *Foeniculum vulgare* Mill.-derived SeNP to treat rheumatoid arthritis. Not only would this approach directly target the inflammatory pathways characteristic of rheumatoid arthritis but also fulfill the selenium deficiency which would consequently assist the selenoproteins dependent redox regulatory processes in restoring the body's oxidative balance. To the best of our knowledge, previous studies have highlighted the individual benefits of these constituents, but their combined effect has not been checked before for the treatment of rheumatoid arthritis.

Materials And Methods {#S0002}
=====================

Preparation Of *Foeniculum vulgare* Mill. Seed Extract {#S0002-S2001}
------------------------------------------------------

After collection of dried *Foeniculum vulgare* Mill. seeds from a local source, their morphology was analyzed and verified using previously published literature. Plant seed extract was prepared by mixing 7 g of ground dried seeds in 100 mL deionized water which was kept in shaking incubator for 24 hrs at 40°C in dark conditions at a speed of 2000 rpm. Later, it was centrifuged at 6000 rpm at 4°C and then filtered.

Synthesis Of SeNP From *Foeniculum vulgare* Mill. Seed Extract {#S0002-S2002}
--------------------------------------------------------------

To prepare 100 mL (10 mM) nanoparticle reaction mixture, 173 mg of sodium selenite salt was homogenized in 90 mL deionized water. Then, 10 mL previously prepared plant seed extract was added to it. This reaction mixture was kept in shaking incubator for 72 hrs at 40°C at 2000 rpm in dark conditions. The reaction mixture was initially yellow and turned brick red by the end of 72 hrs. For purification, the supernatant was discarded and deionized water was used to give two washes to the nanoparticle pellet. This was done for 20 mins each at 6000 rpm in a centrifuge using 15 mL falcon tubes. The nanoparticle pellet settled down and was dried at 150°C on a hot plate in a china dish.

Characterization Of SeNP {#S0002-S2003}
------------------------

SeNP were characterized by multiple techniques. UV-Visible (UV-Vis) analysis of plant seed extract and nanoparticle reaction mixture was carried out by spectrophotometer (A & E Lab, Guangzhou, Guangdong, China). Fourier transform infrared spectroscopy (FTIR) analysis was performed using spectrophotometer (Perkin-Elmer Spectrum-100 FTIR Spectrophotometer, Waltham, Massachusetts, United States). Sigma-Aldrich infrared spectrum table was used for finding functional groups corresponding to the frequency peaks. X-ray diffraction (XRD) analysis was performed on powdered nanoparticles in angle range of 10 to 20 theta (ϴ) using X-ray diffractometer (D8 ADVANCE BRUKER, AXS, Germany). Scanning electron microscopy (SEM) analysis was performed using SEM system (TESCAN VEGA 3 tungsten thermionic emission, model 51-ADD0007, sensor 51-1385-046, Kohoutovice, Czech Republic) at the resolution power 5.9 KeV. Energy-dispersive X-ray spectroscopy (EDS) analysis was performed using EDS instrument (Oxford X-act, Tubney Woods Abingdon, Oxfordshire, United Kingdom).

Toxicity Analysis Of Biosynthesized SeNP {#S0002-S2004}
----------------------------------------

Toxicity analysis was conducted on healthy mice to check the biosafety profile of synthesized SeNP. Twenty female Balb/c mice at age eight to twelve weeks were divided into five groups (four mice/group) as depicted in [Table 1](#T0001){ref-type="table"}. One group consisted of healthy control mice while the rest of the four groups were given SeNP in their feed at 2.5 mg/kg, 5 mg/kg, 10 mg/kg and 20 mg/kg doses, respectively, for fourteen consecutive days. At the end of fourteen days, dissection was performed after overnight fasting. Organs comprising liver, kidney and spleen and serum of the mice were collected. Clinical chemistry parameters including liver function tests (total bilirubin, alanine aminotransferase (ALT), alkaline phosphate (ALK)) and renal function tests (urea and creatinine) were evaluated using the collected serum and histological examination was performed on spleen, liver and kidneys of mice. The purpose of conducting these tests was to check if SeNP caused any adverse effects on the enzyme levels or the aforementioned organs.Table 1Experimental Grouping For Toxicity AnalysisGroup NumberGroup TypeAdministrationNo. Of Mice1Control Healthy MiceStandard Feed42Healthy Mice2.5 mg/kg dose of SeNP43Healthy Mice5 mg/kg dose of SeNP44Healthy Mice10 mg/kg dose of SeNP45Healthy Mice20 mg/kg dose of SeNP4[^1]

Collagenase Type 2-Induced Arthritic Animal Model Construction {#S0002-S2005}
--------------------------------------------------------------

Thirty female Balb/c mice were divided into five groups of six mice each as depicted in [Table 2](#T0002){ref-type="table"}. Arthritis was induced in mice in four of these groups. In the first step of arthritis induction protocol, 0.1 M acetic acid was mixed in Hartman solution in 2:1. Then, 2 mg of collagenase type 2 (Worthington Biochemical Corporation, Lakewood, New Jersey, United States) was added to 1 mL of the above prepared solution to make 1 mL collagenase type 2 solution. This mixture was kept at 4°C overnight in a shaking incubator. Bovine serum albumin (BSA) was dissolved in Hartmann solution (1:1). Collagenase type 2 was mixed in complete Freund's adjuvant (Sigma-Aldrich, St. Louis, Missouri, United States) in 1:1 and vortexed for 2 to 3 mins. Then, BSA was added into it in 2:1. This mixture was thoroughly mixed in an Eppendorf tube with the help of a pipette. Then, 0.2 mL (2 µl) of this solution was filled into each syringe. Three injections containing the above mixture were administered subcutaneously in the tail on day 0, 7 and 14. The fourth and fifth injections comprised 150 µL of complete Freund's adjuvant and were administered in the right hind paws of mice on day 21 and 28. The protocol lasted twenty-eight days. Paw volume of all mice was measured at day 0, 7, 14, 21 and 28 using a vernier caliper. By the end of RA induction protocol, swelling and difficulty in motility were visible in mice. Inflammation severity was graded, and grade 3 and 4 scoring mice were further experimented on.[@CIT0021] Previously, Han et al have used collagen type 2 and complete Freund's adjuvant for induction of arthritis in Balb/c mice.[@CIT0022]Table 2Experimental Grouping For Therapeutic AnalysisGroup NumberGroup TypeAdministrationNo. Of Mice1Control Healthy MiceStandard Feed (No addition)62Arthritic MiceStandard Feed (No addition)63Arthritic Mice10 mg/kg dose of Leflunomide (Standard drug for RA) in Standard Feed64Arthritic Mice5 mg/kg dose of SeNP in Standard Feed65Arthritic Mice10 mg/kg dose of SeNP in Standard Feed6[^2]

Administration Of Therapeutic SeNP Doses In Arthritic Mice {#S0002-S2006}
----------------------------------------------------------

Following arthritis induction in mice, the first group containing healthy mice and second group now categorized as untreated arthritic control mice were given standard laboratory feed for fourteen consecutive days. Third group was classified as the one receiving standard drug and was given leflunomide in 10 mg/kg dose for fourteen consecutive days. Fourth and fifth groups comprised the experimental treatment groups. They were administered 5 mg/kg and 10 mg/kg SeNP in their feed, respectively, for fourteen consecutive days. During this time, paw volume of all mice was measured on day 0, 7 and 14 of feed administration. At the end of fourteen days, the mice were dissected following overnight fasting and specimen (serum, spleen, liver and hind paws) were collected, their clinical chemistry parameters were measured using serum and histological analysis of paw tissues was carried out. Spleen indices were calculated to check if the nanoparticles caused splenomegaly.[@CIT0021] For the determination of antioxidant activity, 2,2-diphenyl-1-picrylhydrazyl (DPPH 95%, Alfa Aesar, Ward Hill, MA, USA) assay was performed on treated mice serum. Change of DPPH color from violet to yellow is an indication of free radicals being scavenged. Catalase activity was checked in mice liver tissues for further evaluation of antioxidant activity of SeNP.[@CIT0023]--[@CIT0026]

Statistical Analysis {#S0002-S2007}
--------------------

Statistical analysis was performed using IBM SPSS Statistics version 21 and GraphPad Prism 5. Variance among groups was evaluated using one-way ANOVA followed by Student *T* test and two-way ANOVA along with Bonferroni Post-test. Values with differences P \< 0.05, P \< 0.01 and P \< 0.001 were considered to be statistically significant.

Results And Discussion {#S0003}
======================

Synthesis Of *Foeniculum vulgare* Mill.-Derived SeNP {#S0003-S2001}
----------------------------------------------------

The SeNP reaction mixture that was kept in shaking incubator for 72 hrs, changed color from yellow to brick red. This served as a primary visual indication of successful SeNP synthesis ([Figure 1](#F0001){ref-type="fig"}). The characteristic red color of biosynthesized SeNP has been reported by previous studies as well.[@CIT0027]Figure 1Color transformation of selenium nanoparticle reaction mixture from yellow to brick red depicting successful synthesis of selenium nanoparticles.

Characterization Of Biosynthesized SeNP {#S0003-S2002}
---------------------------------------

A comparative UV-Visible spectroscopy analysis of absorption spectra of fennel seed extract ([Figure 2A](#F0002){ref-type="fig"}) and SeNP ([Figure 2B](#F0002){ref-type="fig"}) showed that plant seed extract had multiple constituent compounds which were evident through the multiple peaks, but the SeNP reaction mixture showed a single sharp peak at 275 nm. The absence of any other peak in the SeNP reaction mixture absorption spectrum also indicated that the synthesized nanoparticles were made of pure selenium and there was no impurity.Figure 2(**A**) Ultraviolet-visible spectrum of *Foeniculum vulgare* Mill. seed extract depicting presence of multiple peaks indicating various constituent compounds. (**B**) Ultraviolet-visible spectrum of selenium nanoparticle reaction mixture indicating specific selenium nanoparticle absorbance peak at 275 nm.

Similarly, FTIR spectroscopy analysis of fennel seed extract ([Figure 3A](#F0003){ref-type="fig"}) compared to SeNP reaction mixture ([Figure 3B](#F0003){ref-type="fig"}) showed change in absorption peaks. This proved that chemically active compounds in fennel seed extract caused reduction of sodium selenite ions into elemental selenium which consequently resulted in formation of SeNP.Figure 3(**A**) Infrared spectrum of *Foeniculum vulgare* Mill. seed extract prior to its interaction with sodium selenite solution. (**B**) Infrared spectrum of selenium nanoparticles reaction mixture synthesized after interaction of *Foeniculum vulgare* Mill. seed extract with sodium selenite solution.

XRD analysis showed sharp specific diffraction peaks ([Figure 4](#F0004){ref-type="fig"}) at 2ϴ values 23.28, 29.50, 41.26, 43.51, 45.24, 51.29, 55.61, 61.50 and 65.29. These 2ϴ values corresponded to reflections at 100, 101, 110, 012, 111, 201, 003, 022 and 210, respectively, from crystalline SeNP (JCPDS number: 03-065-1876). Similar reflection values have been reported by previous studies conducted on biosynthesis and characterization of SeNP.[@CIT0028]Figure 4X-ray diffraction pattern of selenium nanoparticles derived from *Foeniculum vulgare* Mill. seed extract.

SEM analysis showed spherical to irregular morphology of SeNP ([Figure 5](#F0005){ref-type="fig"}). The average nanoparticle size measurement from SEM image turned out to be 47.14 nm. Previous studies reveal that nanoparticles that range in size from 10 to 60 nm exhibit maximum cellular uptake in non-phagocytic cells.[@CIT0029]Figure 5Scanning electron microscopic images of selenium nanoparticles derived from *Foeniculum vulgare* Mill. seed extract at 2 µm, 1 µm and 500 nm depicting spherical to irregular morphology of selenium nanoparticles.

EDS analysis highlighted specific selenium peaks at three points ([Figure 6](#F0006){ref-type="fig"}). The presence of elements like carbon, calcium, oxygen and sodium in the graph can be attributed to plant (organic) source of nanoparticle synthesis.Figure 6Energy Dispersive X-Ray Spectroscopy analysis graph depicting energy on X-axis and number of counts on Y-axis representing elemental composition of *Foeniculum vulgare* Mill.-derived selenium nanoparticles. Selenium spectrum peaks are shown by arrows.

Clinical Chemistry Parameters Of SeNP-Administered Healthy Mice {#S0003-S2003}
---------------------------------------------------------------

Comparison of ALT, total bilirubin, creatinine and urea values of healthy control mice and the groups administered four doses of SeNP showed insignificant differences. However, ALK value of groups that received 10 mg/kg and 20 mg/kg dose of SeNP showed significant difference (P \<0.05) from the healthy mice ([Table 3](#T0003){ref-type="table"}). This may be attributed to the fact that these two doses increased the selenium levels in the serum and this excess selenium ultimately caused deviation in the ALK values. Previously, Hoffman has reported variation in ALK values due to selenium toxicity.[@CIT0030]Table 3Clinical Chemistry Parameters Of Healthy Mice Administered Four Doses Of SeNP (Toxicity Analysis)Clinical Chemistry ParametersHealthy ControlSeNP 2.5 mg/kgSeNP 5 mg/kgSeNP 10 mg/kgSeNP 20 mg/kgALT (U/L)60.67±14.5765.33±16.1652.50±24.7543.67±10.9745.50±4.95ALK (U/L)58.33±8.0859.67±12.9049.00±19.8080.33±3.51\*31.50±4.95\*TB (mg/dL)0.47±0.250.20±0.170.10±0.000.17±0.110.45±0.35Creatinine(mg/dL)0.6±0.170.45±0.350.40±0.281.20±0.000.45±0.35Urea (mg/dL)49±0.0049.00±9.9052.50±4.9549.00±9.9045.50±4.95[^3][^4]

Histopathological Analysis Of SeNP-Administered Healthy Mice {#S0003-S2004}
------------------------------------------------------------

Spleen, liver and kidney sections of healthy mice and the mice comprised in the groups that received four different doses of SeNP are depicted in [Figure 7](#F0007){ref-type="fig"}. Histopathological analysis of spleen showed intact red and white pulp in all groups ([Figure 7A](#F0007){ref-type="fig"}--[E](#F0007){ref-type="fig"}). The liver of healthy mice and all four groups given SeNP showed intact hepatocellular morphology ([Figure 7F](#F0007){ref-type="fig"}--[J](#F0007){ref-type="fig"}). The kidney sections of healthy mice and those that received 5 mg/kg, 10 mg/kg and 20 mg/kg doses of SeNP showed intact glomerular structures ([Figure 7K](#F0007){ref-type="fig"}--[O](#F0007){ref-type="fig"}). Whereas, the group that received 2.5 mg/kg dose of SeNP showed somewhat distorted glomeruli ([Figure 7L](#F0007){ref-type="fig"}). Glomerular distortion has been reported in the past by Kumar, Gautam and Sinha in selenium-administered broiler birds.[@CIT0031]Figure 7Histopathological cross-sections of SeNP administered (doses 2.5 mg/kg, 5 mg/kg, 10 mg/kg and 20 mg/kg) mice spleens compared to healthy control spleen at magnification 4X depicted clearly defined red and white pulp in all mice groups (**A**, **B**, **C**, **D**, **E**). Histological longitudinal sections of SeNP administered (doses 2.5 mg/kg, 5 mg/kg, 10 mg/kg and 20 mg/kg) mice livers compared to healthy control liver depicted intact hepatocellular morphology at 40X magnification in all mice groups (**F**, **G**, **H**, **I**, **J**). Histological bisections of SeNP-administered (doses 5 mg/kg, 10 mg/kg and 20 mg/kg) mice kidneys compared to healthy control kidney at 40X magnification depicted intact glomerular structures (**K**, **M**, **N**, **O**). Mice administered 2.5 mg/kg dose of selenium nanoparticles showed somewhat distorted glomeruli (**L**).**Abbreviation:** SeNP, selenium nanoparticles.

Paw Swelling In RA-Induced Mice {#S0003-S2005}
-------------------------------

A significant increase in paw volume (P \< 0.001) at day 14, 21 and 28 was evident in experimental mice compared to healthy control mice ([Figure 8A](#F0008){ref-type="fig"}). The difference in swelling can be witnessed in [Figure 8B](#F0008){ref-type="fig"}. In addition, redness was also observed. These observations indicated that RA was successfully induced in mice.Figure 8(**A**) Asterisks (\*\*\*) indicate significant increase (P \< 0.001) in paw volume at day 14, 21 and 28 during rheumatoid arthritis induction period. (**B**) Ventral and dorsal view of paw of a healthy mouse and a mouse with rheumatoid arthritis.**Abbreviation:** RA, rheumatoid arthritis.

Reduction In Paw Volume Of Treated Arthritic Mice {#S0003-S2006}
-------------------------------------------------

Paw volume of untreated arthritic mice kept increasing till day 14 as evident in [Figure 9A](#F0009){ref-type="fig"}. In contrast, the groups of mice treated with SeNP showed decrease in paw volume. Mice that were treated with 5 mg/kg dose of SeNP showed comparatively less decrease in paw volume (P \< 0.05). Mice treated with 10 mg/kg dose of SeNP showed greater decrease in paw volume (P \< 0.01), while the group of mice that were treated with standard arthritic drug leflunomide showed greatest decrease in paw volume (P \< 0.001). A pictorial depiction of gross changes in treated and untreated mice groups is shown in [Figure 9B](#F0009){ref-type="fig"}.Figure 9(**A**) Reduction in paw volume in 5mg/kg SeNP (P \<0.05), 10mg/kg SeNP (P \< 0.01) and leflunomide (P\<0.001) treated groups as compared to arthritic control group. (**B**) Ventral and dorsal paw view of arthritic group compared to groups treated with 5mg/kg SeNP, 10mg/kg SeNP and leflunomide.**Abbreviations:** SeNP, selenium nanoparticles; RA, rheumatoid arthritis.

Histopathological Analysis Of Treated Arthritic Mice Paw Tissues {#S0003-S2007}
----------------------------------------------------------------

Histopathological analysis of untreated arthritic mice paw tissue showed bone erosion and distorted cellular morphology ([Figure 10](#F0010){ref-type="fig"}), whereas, photomicrographs of paw tissues from SeNP-treated groups (5 mg/kg and 10 mg/kg) as well as leflunomide-treated group showed restored cellular morphology and no signs of erosion. Paw tissue from healthy mice is also shown for comparison ([Figure 10](#F0010){ref-type="fig"}).Figure 10A comparative histological analysis of paw tissues from the treated and untreated groups of mice. Bone erosion and distorted cellular morphology are visible in arthritic mice (RA), whereas selenium nanoparticles treated groups display somewhat restored cellular morphology.**Abbreviations:** RA, rheumatoid arthritis; SeNP, selenium nanoparticles.

Radical Scavenging Activity Of Treated Arthritic Mice Serum {#S0003-S2008}
-----------------------------------------------------------

DPPH assay was conducted to measure antioxidant or radical scavenging potential of SeNP treated mice serum compared to untreated mice serum. Mice that received 10 mg/kg dose of SeNP showed significant increase in radical scavenging activity as compared to untreated arthritic mice serum (P \< 0.05) as shown in [Figure 11](#F0011){ref-type="fig"}. The serum of mice treated with leflunomide also showed a considerable antioxidant potential compared to the arthritic group (P \< 0.01). Biosynthesized SeNP showed moderate DPPH scavenging activity in a study conducted by Forootanfar et al.[@CIT0032]Figure 11Graph depicts DPPH radical scavenging activity of 5 mg/kg SeNP, 10 mg/kg SeNP and leflunomide in serum as compared to untreated arthritic mice serum. Leflunomide showed most significant antioxidant activity (P \< 0.01) shown by \*\* in graph. SeNP in 10 mg/kg dose showed significant antioxidant activity (P \< 0.05) shown by \* in graph. 5mg/kg SeNP showed non-significant antioxidant activity.**Abbreviations:** RA, rheumatoid arthritis; SeNP, selenium nanoparticles.

Catalase Enzyme Activity Of Treated Arthritic Mice Liver Tissues {#S0003-S2009}
----------------------------------------------------------------

Comparison of catalase enzyme activity of untreated and treated mice liver tissues showed no significant difference ([Figure 12](#F0012){ref-type="fig"}). This may be attributed to the fact that used liver tissues were preserved for a few days. Fresh tissue samples may exhibit different results. Ashouri et al reported significant increase in catalase activity in nano-selenium fed *Cyprinus carpio* liver tissues.[@CIT0033]Figure 12Catalase activity shown by treated mice liver tissues compared to untreated mice liver tissue. Variation in catalase activity values was not significant.**Abbreviations:** RA, rheumatoid arthritis; SeNP, selenium nanoparticles.

Spleen Indices Of Treated Arthritic Mice {#S0003-S2010}
----------------------------------------

Spleen indices of treated as well as untreated groups showed no significant difference. This shows that biosynthesized SeNP did not have any adverse effects on spleen and did not cause splenomegaly ([Figure 13](#F0013){ref-type="fig"}). Hyperplasia of spleen has been reported previously in rats at some doses of SeNP.[@CIT0034]Figure 13Spleen Indices of selenium nanoparticles (5 mg/kg and 10 mg/kg) and leflunomide-treated groups in comparison with healthy control and untreated arthritic group. There was no significant difference in spleen index of any experimental group compared to the control group depicting that selenium nanoparticles did not cause splenomegaly.**Abbreviations:** RA, rheumatoid arthritis; SeNP, selenium nanoparticles.

Clinical Chemistry Parameters Of Treated Arthritic Mice {#S0003-S2011}
-------------------------------------------------------

Oral administration of SeNP in 5 mg/kg and 10 mg/kg doses showed no significant difference in the ALT, total bilirubin, urea and creatinine values of treated mice compared to healthy controls. However, mice treated with 5 mg/kg dose of SeNP and untreated arthritic mice showed significant difference in ALK values as compared to healthy control mice (P \< 0.05). It indicates that 5 mg/kg dose of SeNP was not effective in restoring the ALK values that got increased in arthritic mice. This is depicted in [Table 4](#T0004){ref-type="table"}.Table 4Clinical Chemistry Parameters Of SeNP-Treated And SeNP-Untreated Arthritic Mice (Therapeutic Analysis)Clinical Chemistry ParametersHealthy ControlRALeflunomide (10 mg/kg)SeNP (5 mg/kg)SeNP (10 mg/kg)ALT(U/L)28.000±9.00037.000±15.55618.666±10.26343.000±4.24226.500±9.192ALK(U/L)65.000±7.81093.000±0.000\*65.666±18.55689.000±16.970\*61.000±8.485TB(mg/dL)0.063±0.0050.050±0.0280.470±0.4050.150±0.0700.165±0.049Urea(mg/dL)46.333±5.03346.500±10.60645.666±20.59941.500±4.94947.000±12.727Creatinine(mg/dL)0.240±0.0520.240±0.0140.763±0.0980.735±0.0070.595±0.021[^5][^6]

Biogenic SeNP find applications in various fields. They are utilized as anti-cancer, anti-oxidant and antimicrobial agents in medicine. Nanobiosensors employing SeNP have been reported to detect hydrogen peroxide. Another study reported use of amorphous biogenic SeNP for removing mercury from contaminated water.[@CIT0035]

Conclusion {#S0004}
==========

In a recent study conducted by Ren et al, commercially available SeNP dispersed in a specific type of phytochemical exhibited significant anti-inflammatory potential in arthritic rat model.[@CIT0036] Our study also reinforces the therapeutic nature of SeNP. According to our study, *Foeniculum vulgare* Mill. seed extract-derived SeNP retain a good biosafety profile in case of oral route of administration. They exhibited significant anti-arthritic and antioxidant activity which emphasizes their potential as a promising alternative treatment option for rheumatoid arthritis.

Abbreviations {#S0005}
=============

RA, rheumatoid arthritis; SeNP, selenium nanoparticles; NSAIDs, non-steroidal anti-inflammatory drugs; DMARDS, disease-modifying anti-rheumatic drugs; MTX, methotrexate; UV-Vis, ultraviolet visible; FTIR, Fourier transform infrared; XRD, X-ray diffraction; SEM, scanning electron microscopy; EDS, energy dispersive X-ray spectroscopy; ALT, alanine aminotransferase; ALK, alkaline phosphatase; TB, total bilirubin; U/L, units per liter; mg/dL, milligrams per deciliter; mg/kg, milligrams per kilogram; DPPH, 2,2-Diphenyl-1-picrylhydrazyl; BSA, bovine serum albumin.
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[^1]: **Abbreviations:** mg/kg, milligrams per kilogram; SeNP, selenium nanoparticles.

[^2]: **Abbreviations:** mg/kg, milligrams per kilogram; SeNP, selenium nanoparticles.

[^3]: **Notes:** Asterisk (\*) indicates significant difference (P\<0.05) in the ALK values of SeNP (10 mg/kg) and SeNP (20 mg/kg) treated groups as compared to healthy control group.

[^4]: **Abbreviations:** SeNP, selenium nanoparticles; mg/kg, milligrams per kilogram; ALT, alanine Aminotransferase; ALK, alkaline phosphatase; TB, total bilirubin; U/L, units per liter; mg/dL, milligrams per deciliter.

[^5]: **Notes:** Asterisk (\*) indicates significant difference (P\<0.05) in the ALK value of arthritic group and SeNP (5 mg/kg) treated group as compared to healthy control group.

[^6]: **Abbreviations:** RA, rheumatoid arthritis; SeNP, selenium nanoparticles; ALT, alanine aminotransferase; ALK, alkaline phosphatase; TB, total bilirubin; U/L, units per liter; mg/dL, milligrams per deciliter; mg/kg, milligrams per kilogram.
